# Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients

> **NCT05445024** · NA · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Laparoscopic
- Gastrointestinal Surgery

## Interventions

- **PROCEDURE:** nalbuphine group
- **PROCEDURE:** sufentanil group

## Key facts

- **NCT ID:** NCT05445024
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05445024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05445024, "Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05445024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*